Home › Companies › Arcturus Therapeutics Holdings Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2026: 10 items on Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed June 5, 2026: 8 elected · 2 approved.
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Arcturus Therapeutics Holdings Inc. in the interactive database Compare manager voting policies
These tallies are Arcturus Therapeutics Holdings Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Peter Farrell | 15,641,369 | -- | -- | 116,895 | 5,676,925 | 99.3% | Elected | — |
| Elect Director: Joseph E. Payne | 15,660,970 | -- | -- | 97,294 | 5,676,925 | 99.4% | Elected | — |
| Elect Director: James Barlow | 15,618,263 | -- | -- | 140,001 | 5,676,925 | 99.1% | Elected | — |
| Elect Director: Dr. Edward W. Holmes | 15,521,066 | -- | -- | 237,198 | 5,676,925 | 98% | Elected | — |
| Elect Director: Dr. Magda Marquet | 15,616,156 | -- | -- | 142,108 | 5,676,925 | 99.1% | Elected | — |
| Elect Director: Dr. Jing L. Marantz | 15,626,241 | -- | -- | 132,023 | 5,676,925 | 99.2% | Elected | — |
| Elect Director: Dr. John H. Markels | 15,633,667 | -- | -- | 124,597 | 5,676,925 | 99.2% | Elected | — |
| Elect Director: Dr. Moncef Slaoui | 15,643,492 | -- | -- | 114,772 | 5,676,925 | 99.3% | Elected | — |
| Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement | 15,254,240 | 327,647 | 176,375 | -- | 5,676,927 | 98% | Approved | — |
| Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2026, as provided in Proposal Number 3 of the Proxy Statement | 21,378,017 | 46,823 | 10,349 | -- | -- | 99.8% | Approved | — |
Source: Arcturus Therapeutics Holdings Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
144 asset managers disclosed a vote on at least one Arcturus Therapeutics Holdings Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.0% for (June 6, 2025 meeting) ▲ 1.5 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Edward W. Holmes”): 15,521,066 for, 237,198 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,470,985 for, 72,947 withheld, 258 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,550,893 | 0 | 1 | 1,159 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 0 | 0 | 0 | 32,737 | Withhold |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 16,242 | Withhold |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 0 | 12,213 | Withhold |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 98.3% for (June 6, 2025 meeting) ▲ 0.8 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Jing L. Marantz”): 15,626,241 for, 132,023 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,539,348 for, 4,841 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,549,663 | 0 | 0 | 2,389 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 99.2% for (June 6, 2025 meeting) unchanged
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. John H. Markels”): 15,633,667 for, 124,597 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,539,348 for, 4,841 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,549,663 | 0 | 0 | 2,389 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Prior year: 98.3% for (June 6, 2025 meeting) ▲ 0.8 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Magda Marquet”): 15,616,156 for, 142,108 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,541,665 for, 2,524 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,549,663 | 0 | 0 | 2,389 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Prior year: 99.7% for (June 6, 2025 meeting) ▼ 0.4 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Moncef Slaoui”): 15,643,492 for, 114,772 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,540,714 for, 3,476 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,550,894 | 0 | 0 | 1,159 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Prior year: 98.9% for (June 6, 2025 meeting) ▲ 0.4 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Dr. Peter Farrell”): 15,641,369 for, 116,895 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,541,665 for, 2,524 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,549,663 | 0 | 0 | 2,389 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Prior year: 98.4% for (June 6, 2025 meeting) ▲ 0.7 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: James Barlow”): 15,618,263 for, 140,001 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,540,506 for, 3,683 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,548,504 | 0 | 0 | 3,548 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Prior year: 99.0% for (June 6, 2025 meeting) ▲ 0.4 pts
Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Elect Director: Joseph E. Payne”): 15,660,970 for, 97,294 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 15,641,369 | 116,895 | 5,676,925 (2) Joseph E. Payne | 15,660,970 | 97,294 | 5,676,925 (3) James Barlow | 15,618,263 | 140,001 | 5,676,…”
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,541,665 for, 2,524 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,549,663 | 0 | 0 | 2,389 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 96.9% for (June 6, 2025 meeting) ▲ 1.0 pts
Description as filed by funds: Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement”): 15,254,240 for, 327,647 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal was approved.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,552,051 | 1 | 0 | 0 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 23,146 | 0 | 0 | 0 | For |
| American Century | 0 | 21,186 | 0 | 0 | Against |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 16,344 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
Fund voting reports, all 52 managers: 7,539,345 for, 21,188 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Amova Asset Management Co., Ltd. | 2,282,695 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| BlackRock | 604,202 | 37 | 0 | 0 | For |
| Empire Life Investments Inc. | 383,493 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| State Street | 201,694 | 1,719 | 0 | 0 | For |
| HEARTLAND ADVISORS INC | 0 | 171,800 | 0 | 0 | Against |
| Two Sigma | 159,066 | 0 | 0 | 0 | For |
| ARK Investment Management LLC | 137,222 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 130,718 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 123,904 | 0 | 0 | 0 | For |
| Northern Trust | 109,772 | 815 | 0 | 0 | For |
| Goldman Sachs | 75,840 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 69,694 | 0 | 0 | 0 | For |
| Vanguard | 52,190 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 37,415 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 35,986 | 0 | 0 | 0 | For |
| SEI | 35,837 | 0 | 0 | 0 | For |
| DE Shaw | 34,229 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 32,153 | 0 | 0 | 0 | For |
| Russell Investments | 31,619 | 0 | 0 | 0 | For |
| AQR | 29,635 | 0 | 0 | 0 | For |
| AllianceBernstein | 27,720 | 0 | 0 | 0 | For |
| Green Alpha Advisors, LLC | 0 | 25,092 | 0 | 0 | Against |
| Point72 | 23,668 | 0 | 0 | 0 | For |
Institutional-manager reports, all 109 managers: 7,240,060 for, 239,485 against. Showing the 25 largest; every one is in the interactive database (link above).
99.8% Approved · of votes cast
Prior year: 99.9% for (June 6, 2025 meeting) ▼ 0.1 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Arcturus Therapeutics Holdings Inc.’s own tally for this item (“Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2026, as provided in Proposal Number 3 of the Proxy Statement”): 21,378,017 for, 46,823 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2026, as provided in Proposal Number 3 of the Proxy Statement”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 7,537,388 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 2,666,411 | 0 | 0 | 0 | For |
| Federated Hermes | 2,209,148 | 0 | 0 | 0 | For |
| Vanguard | 1,552,053 | 0 | 0 | 0 | For |
| BlackRock | 386,889 | 0 | 0 | 0 | For |
| Charles Schwab | 228,627 | 0 | 0 | 0 | For |
| Fidelity | 140,441 | 0 | 0 | 0 | For |
| MFS | 49,584 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 32,737 | 0 | 0 | 0 | For |
| Equitable | 29,257 | 0 | 0 | 0 | For |
| American Century | 21,186 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,071 | 0 | 0 | 0 | For |
| Allspring | 17,573 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 16,344 | 0 | 0 | 0 | For |
| Global X | 16,242 | 0 | 0 | 0 | For |
| Nationwide | 15,751 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 13,370 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 13,200 | 0 | 0 | 0 | For |
| Russell Investments | 12,213 | 0 | 0 | 0 | For |
| Goldman Sachs | 11,656 | 0 | 0 | 0 | For |
| Pacific Life | 9,814 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 9,251 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 8,913 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,200 | 0 | 0 | 0 | For |
| Invesco | 5,575 | 0 | 0 | 0 | For |
| ProShares | 4,819 | 0 | 0 | 0 | For |
Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 28,423,069 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 9.38% |
| 2 | Federated Hermes | 7.77% |
| 3 | Vanguard | 5.46% |
| 4 | BlackRock | 1.36% |
| 5 | Charles Schwab | 0.80% |
| 6 | Fidelity | 0.49% |
| 7 | MFS | 0.17% |
| 8 | SEI Exchange Traded Funds | 0.12% |
| 9 | Equitable | 0.10% |
| 10 | CLEARWATER INVESTMENT TRUST | 0.08% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Amova Asset Management Co., Ltd. | 8.03% |
| 2 | Federated Hermes | 7.77% |
| 3 | BlackRock | 2.13% |
| 4 | Empire Life Investments Inc. | 1.35% |
| 5 | Charles Schwab | 0.80% |
| 6 | State Street | 0.72% |
| 7 | HEARTLAND ADVISORS INC | 0.60% |
| 8 | Two Sigma | 0.56% |
| 9 | ARK Investment Management LLC | 0.48% |
| 10 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.46% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Federated Hermes, Inc. | 3,303,640 | 11.62% | Schedule 13G, filed January 8, 2026 |
| BlackRock | 2,613,281 | 9.19% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 2,089,641 | 7.35% | Form 13F, quarter ended March 31, 2026 |
| Two Sigma | 1,081,784 | 3.81% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 660,928 | 2.33% | Form 13F, quarter ended March 31, 2026 |
| State Street | 543,863 | 1.91% | Form 13F, quarter ended March 31, 2026 |
| Millennium Management | 478,557 | 1.68% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 288,355 | 1.01% | Form 13F, quarter ended March 31, 2026 |
| D.E. Shaw | 252,034 | 0.89% | Form 13F, quarter ended March 31, 2026 |
| Northern Trust | 219,613 | 0.77% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 28,423,069 shares outstanding, as reported by Arcturus Therapeutics Holdings Inc. on its Form 10-Q dated May 5, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Arcturus Therapeutics Holdings Inc.'s shareholder meeting held June 5, 2026, in the 2025-2026 proxy season, 144 asset managers reported votes on at least one of its 10 ballot items in their SEC Form N-PX filings, covering 1,687 separate fund positions. On the most widely held item on that ballot — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — Arcturus Therapeutics Holdings Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Arcturus Therapeutics Holdings Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arcturus Therapeutics Holdings Inc.’s 10-Q dated May 5, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Arcturus Therapeutics Holdings Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Arcturus Therapeutics Holdings (ARCT) 2026 Annual Meeting”, https://proxyvotesnow.com/company/arcturus-therapeutics-holdings-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.